Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Cadranel

Showing results (61-70 of 329) with videos related to

Pageof 33
Sort By:
Chest|December 8, 2011
Multigene mutation analysis on cytologic samplesJocelyne Fleury-Feith, Valérie Gounant, Roger Lacave, et al.
Respiratory Medicine and Research|September 17, 2024
Sarcoid-like reaction related to ALK-ROS inhibitors in lung cancer patientsClara Morin, Thomas Villeneuve, Emma Norkowski, et al.
Lung Cancer (Amsterdam, Netherlands)|November 23, 2005
Lung cancer, a new challenge in the HIV-infected populationArmelle Lavolé, Marie Wislez, Martine Antoine, et al.
Respiratory Medicine and Research|June 11, 2023
PDL1-status predicts primary resistance of metastatic, EGFR-mutated non small cell lung cancers to EGFR tyrosine-kinase inhibitorsJulie Lasvergnas, Vincent Fallet, Boris Duchemann, et al.
Bulletin Du Cancer|November 10, 2012
[CT screening for lung cancer]Valérie Gounant, Jalal Assouad, Armelle Lavolé, et al.
Frontiers in Medicine|October 18, 2021
Case Report: Two Rare Cases of Complete Metabolic Response to Crizotinib in Patients With Rearranged ROS1 and ALK Metastatic Non-small Lung CancerKarim Amrane, Luca Campedel, Coline Le Meur, et al.
The European Respiratory Journal|October 4, 2016
Pulmonary mucosa-associated lymphoid tissue lymphoma revisitedRaphael Borie, Marie Wislez, Martine Antoine, et al.
Chest|July 17, 2012
MALT1 Rearrangements in BAL FluidRaphael Borie, Marie Wislez, Jocelyne Fleury-Feith, et al.
The Lancet. Oncology|October 13, 2009
Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort studyMarguerite Guiguet, François Boué, Jacques Cadranel, et al.
Lung Cancer (Amsterdam, Netherlands)|April 7, 2009
Major and prolonged response to pemetrexed in two cases of lung adenocarcinoma with bronchioloalveolar carcinoma featuresMichaël Duruisseaux, Jacques Cadranel, Elisabeth Biron, et al.
Pageof 33

Showing results (61-70 of 329) with videos related to

Sort By:
Pageof 33
Chest|December 8, 2011
Multigene mutation analysis on cytologic samplesJocelyne Fleury-Feith, Valérie Gounant, Roger Lacave, et al.
Respiratory Medicine and Research|September 17, 2024
Sarcoid-like reaction related to ALK-ROS inhibitors in lung cancer patientsClara Morin, Thomas Villeneuve, Emma Norkowski, et al.
Lung Cancer (Amsterdam, Netherlands)|November 23, 2005
Lung cancer, a new challenge in the HIV-infected populationArmelle Lavolé, Marie Wislez, Martine Antoine, et al.
Respiratory Medicine and Research|June 11, 2023
PDL1-status predicts primary resistance of metastatic, EGFR-mutated non small cell lung cancers to EGFR tyrosine-kinase inhibitorsJulie Lasvergnas, Vincent Fallet, Boris Duchemann, et al.
Bulletin Du Cancer|November 10, 2012
[CT screening for lung cancer]Valérie Gounant, Jalal Assouad, Armelle Lavolé, et al.
Frontiers in Medicine|October 18, 2021
Case Report: Two Rare Cases of Complete Metabolic Response to Crizotinib in Patients With Rearranged ROS1 and ALK Metastatic Non-small Lung CancerKarim Amrane, Luca Campedel, Coline Le Meur, et al.
The European Respiratory Journal|October 4, 2016
Pulmonary mucosa-associated lymphoid tissue lymphoma revisitedRaphael Borie, Marie Wislez, Martine Antoine, et al.
Chest|July 17, 2012
MALT1 Rearrangements in BAL FluidRaphael Borie, Marie Wislez, Jocelyne Fleury-Feith, et al.
The Lancet. Oncology|October 13, 2009
Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort studyMarguerite Guiguet, François Boué, Jacques Cadranel, et al.
Lung Cancer (Amsterdam, Netherlands)|April 7, 2009
Major and prolonged response to pemetrexed in two cases of lung adenocarcinoma with bronchioloalveolar carcinoma featuresMichaël Duruisseaux, Jacques Cadranel, Elisabeth Biron, et al.
Pageof 33